Pappas Capital LLC
05/19/2008 | Press release | Archived content
Jeff Collins was elected to a 3-year term on the Board of Directo...
News | 05. 19. 2008
NCBIO elected four new members to the organization's Board of Directors and re-elected six other individuals at the annual meeting in Winston-Salem, May 19th. Jeff Collins, Executive in Residence, Pappas Ventures; Norris Tolson, President and CEO of the NC Biotechnology Center; Susan Thomason, Executive Director Global Business Development, NovaQuest; and Jan Turek, President and CEO of Biolex Therapeutics will serve until 2011.
Pappas Capital LLC published this content on May 19, 2008, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 22, 2026 at 10:10 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]